TSH BIOPHARM CORP LTD has a total of 12 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Malaysia, Taiwan and United States. Its main competitors in its focus markets pharmaceuticals are 45 SEC LLC, ORASIS PHARMACEUTICALS LTD and ZARODEX THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Malaysia | 2 | |
#2 | Taiwan | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Peru | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Juang Shin-Yi | 5 |
#2 | Wang Hsi-Chieh | 5 |
#3 | Chen Jaw-Wen | 3 |
#4 | Chen Chun-Liang | 3 |
#5 | Lin Chi-Cheng | 3 |
#6 | Sung Kuo-Chun | 3 |
#7 | Chen Pei | 3 |
#8 | Lin Jung-Chin | 2 |
#9 | Hwang Shiu-Ren | 2 |
#10 | Hao Wei Hua | 1 |
Publication | Filing date | Title |
---|---|---|
CN107921042A | Pharmaceutical composition comprising amlodipine and dextromethorphan | |
TW201304775A | Compositions and methods for treating hypertension using eprosartan and amlodipine | |
EP2566478A1 | Pharmaceutical composition and method for treating hypertension | |
TW201110965A | Controlled release carvediolol formulation |